Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marsh & McLennan Companies, Inc. (MRSH) vs SYSCO Corporation (SYY) Price & Performance

Marsh & McLennan Companies, Inc.Trade
SYSCO CorporationTrade

Price performance (Past 24H)

Key statistics

Marsh & McLennan Companies, Inc. vs SYSCO Corporation — how do they compare? Marsh & McLennan Companies, Inc. trades at $175.94 (market cap $84.31B), while SYSCO Corporation trades at $78.1 (market cap $38.47B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 2.2× SYSCO Corporation's market cap, and SYSCO Corporation pays the higher dividend (2.81%). Which is the better fit depends on your goals — on Pluang, investors hold Marsh & McLennan Companies, Inc. for 109 Days and SYSCO Corporation for 77 Days on average.

MRSHSYY
Market Cap
$84.31B$38.47B
Volume
3,948,9474,808,465
Sector
FinancialsConsumer Staples
52-Week High
$207.02$91.16
52-Week Low
$157.32$69.30
Typical Hold Time
109 Days77 Days
Enterprise Value
$104.99B$51.65B
Dividend Yield
2.24%2.81%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marsh & McLennan Companies, Inc.

Marsh (MRSH) trades at $175.76, up 1.21% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The stock is supported by robust fundamentals, including a 25.72% ROE and 14.24% net income margin, alongside the recent acquisition of Accel Holdings announced on October 2, 2026. Revenue has grown steadily, reaching $27.0B in 2025, though profit margins have slightly softened.

The outlook remains positive with a consensus price target of $202.71, implying 15% upside, but risks include high valuation multiples and competitive pressures. Analysts are predominantly neutral, with 65% hold ratings, suggesting cautious optimism amid solid operational performance.

SYSCO Corporation

Sysco Corporation (SYY) trades at $78.14, up 1.76% with neutral technical signals. The company maintains steady revenue growth reaching $81.37B in 2025, though net margins compressed to 2.08%. Recent corporate actions include a $1.5B senior notes offering and a $0.55 dividend declaration. Technical indicators show mixed signals with RSI neutral at 49.4 and ADX suggesting weak trend direction. The stock trades below analyst consensus target of $85.75 with 60% buy ratings.

Sysco presents a balanced investment case with attractive valuation metrics (P/S 0.44) and strong institutional support, offset by margin pressure and elevated debt levels. The AI efficiency program targeting $500M savings by 2029 provides growth catalyst potential. Key risks include competitive pressures in food distribution and sensitivity to economic cycles affecting restaurant demand.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MRSH
100% Buy0% Sell
Avg holding period · 109 Days
SYY

No sentiment data available yet.

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH →

About SYSCO Corporation

Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.

Read more on SYY →